semaglutide mouse ameliorates diabetes-associated cognitive dysfunction in model of type 2 diabetes Semaglutide interferes with postnatal development

In contrast, semaglutide works through a different mechanism that does not affect urinary glucose excretion

In the analysis of patients with T2DM stratified by their having or not having a diagnosis of obesity, we observed that the lower risk of incident AUD with semaglutide in patients without obesity was similar in patients with obesity

Similarly, ophthalmological endpoints were investigated adjusting for (1) papilledema degree, (2) pRNFL thickness, (3) GCL volume, or (3) ONSD at baseline as appropriate and in a second step also for weight loss to evaluate potential independent treatment effects of GLP-1-RAs

Recent work suggests that ghrelin also controls glucose metabolism